DE69016439D1 - Arzneimittel mit verbesserter Auflösungsgeschwindigkeit. - Google Patents

Arzneimittel mit verbesserter Auflösungsgeschwindigkeit.

Info

Publication number
DE69016439D1
DE69016439D1 DE69016439T DE69016439T DE69016439D1 DE 69016439 D1 DE69016439 D1 DE 69016439D1 DE 69016439 T DE69016439 T DE 69016439T DE 69016439 T DE69016439 T DE 69016439T DE 69016439 D1 DE69016439 D1 DE 69016439D1
Authority
DE
Germany
Prior art keywords
improved dissolution
medicines
dissolution rate
pharmaceutical compositions
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69016439T
Other languages
English (en)
Other versions
DE69016439T2 (de
Inventor
Kenji Ogawa
Toshiyuki Shibata
Hirofumi Samemoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Welfide Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welfide Corp filed Critical Welfide Corp
Publication of DE69016439D1 publication Critical patent/DE69016439D1/de
Application granted granted Critical
Publication of DE69016439T2 publication Critical patent/DE69016439T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69016439T 1989-05-30 1990-11-28 Arzneimittel mit verbesserter Auflösungsgeschwindigkeit. Expired - Fee Related DE69016439T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1138340A JPH0818985B2 (ja) 1989-05-30 1989-05-30 溶出性の改良された製剤組成物

Publications (2)

Publication Number Publication Date
DE69016439D1 true DE69016439D1 (de) 1995-03-09
DE69016439T2 DE69016439T2 (de) 1995-06-29

Family

ID=15219630

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69016439T Expired - Fee Related DE69016439T2 (de) 1989-05-30 1990-11-28 Arzneimittel mit verbesserter Auflösungsgeschwindigkeit.

Country Status (5)

Country Link
EP (1) EP0487768B1 (de)
JP (1) JPH0818985B2 (de)
AT (1) ATE117545T1 (de)
DE (1) DE69016439T2 (de)
ES (1) ES2067634T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05255125A (ja) * 1992-02-29 1993-10-05 Upjohn Co:The 徐放性製剤およびその製法
EA004872B1 (ru) * 1999-08-03 2004-08-26 ЛИЛЛИ АЙКОС эЛ-эЛ-Си β-КАРБОЛИНОВЫЕ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
BRPI0708556A2 (pt) * 2006-03-06 2011-05-31 Teva Pharma composição de ezetimiba

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2038708T3 (es) * 1987-03-02 1996-07-16 Yoshitomi Pharmaceutical Metodo para producir compuestos de benzotiepino(5,4-c)piridazina.

Also Published As

Publication number Publication date
JPH032120A (ja) 1991-01-08
JPH0818985B2 (ja) 1996-02-28
DE69016439T2 (de) 1995-06-29
EP0487768B1 (de) 1995-01-25
ATE117545T1 (de) 1995-02-15
ES2067634T3 (es) 1995-04-01
EP0487768A1 (de) 1992-06-03

Similar Documents

Publication Publication Date Title
AU617918B2 (en) 2-aminopyrimidinone derivatives
NO905572L (no) Fremgangsmaate for fremstilling av peptidforbindelser.
ES2044836T3 (es) Derivado de la piperidina, su utilizacion y compuesto farmaceutico que lo contiene.
IL109526A0 (en) Benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
DZ1405A1 (fr) Dérivés de n-(3-hydroxy-4-piperidinyl)(dihydro-benzofuranne, dihydro-2h-benzopy-ranne ou dishydro-benzodioxin)carboxamide.
DE69635996D1 (de) Pharmazeutische zusammensetzungen mit hydroximsäurederivaten
KR970706021A (ko) N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형제제(MEDICINAL ADJUVANTS CONSISTIONG OF AN N-SUBSTITUED-o-TOLUIDING DERIVANTIVE, AND PERCUTANEOUSLY ABSORBALE PREPARATIONS COMPRISING THE ADJUVANTS)
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
DE69016439T2 (de) Arzneimittel mit verbesserter Auflösungsgeschwindigkeit.
ATE161837T1 (de) Benzopyran derivat, seine darstellung und pharmazeutische zusammensetzung, welche dieses enthält
JPS57200361A (en) "indomethacin(r)" pharmaceutical with low irritant action
IL103826A0 (en) Thiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS5735515A (en) Immunoregulating agent
NZ246598A (en) Trazodone derivatives; compounds and preparation, pharmaceutical compositions; intermediate compounds
IE893258L (en) New 2-carbonyl substituted n,n'-di-(trimethoxybenzoyl)¹piperazines, process for preparing the same and¹therapeutical compounds containing them
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
AU1214292A (en) Indane derivatives
IL83216A (en) 1((5-(10->9)abeo-6-methylergolin-8beta-yl)methyl)-imidazolidine-(and hexahydropyrimidine)-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them
MX9202845A (es) Derivado de pradimicina.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee